Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE NORTH AMERICA BIOSTIMULANTS MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7 DBMR MARKET POSITION GRID
2.8 MULTIVARIATE MODELLING
2.9 ACTIVE INGREDIENTS LIFELINE CURVE
2.1 MARKET APPLICATION COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
5 MARKET OVERVIEW
5.1 DRIVERS
5.1.1 INCREASING NEED FOR SUSTAINABLE AGRICULTURE
5.1.2 UPSURGE IN THE DEMAND FOR SEAWEEDS AS RAW MATERIAL
5.1.3 HIGH AGRICULTURAL PRODUCTION WORLDWIDE
5.1.4 HIGH DEMAND FOR ORGANIC FARMING
5.2 RESTRAINT
5.2.1 QUALITY ISSUES IN MANUFACTURING BIOSTIMULANTS
5.3 OPPORTUNITIES
5.3.1 RISING AWARENESS ABOUT BIOSTIMULANTS
5.3.2 STRATEGIC INITIATIVES BY ORGANIZATIONS
5.4 CHALLENGES
5.4.1 HIGH DEMAND FOR SUBSTITUTE PRODUCTS
5.4.2 UNCERTAINTY IN BIOSTIMULANT REGULATION WORLDWIDE
6 NORTH AMERICA BIOSTIMULANTS MARKET BY GEOGRAPHY
6.1 NORTH AMERICA
7 NORTH AMERICA BIOSTIMULANTS MARKET: COMPANY LANDSCAPE
7.1 COMPANY SHARE ANALYSIS: NORTH AMERICA
8 COMPANY PROFILES
8.1 FMC CORPORATION (2022)
8.1.1 COMPANY SNAPSHOT
8.1.2 REVENUE ANALYSIS
8.1.3 COMPANY SHARE ANALYSIS
8.1.4 PRODUCT PORTFOLIO
8.1.5 RECENT DEVELOPMENTS
8.2 SYNGENTA (2022)
8.2.1 COMPANY SNAPSHOT
8.2.2 REVENUE ANALYSIS
8.2.3 COMPANY SHARE ANALYSIS
8.2.4 PRODUCT PORTFOLIO
8.2.5 RECENT DEVELOPMENT
8.3 LALLEMAND INC.
8.3.1 COMPANY SNAPSHOT
8.3.2 COMPANY SHARE ANALYSIS
8.3.3 PRODUCT PORTFOLIO
8.3.4 RECENT DEVELOPMENT
8.4 HAIFA NEGEV TECHNOLOGIES LTD.
8.4.1 COMPANY SNAPSHOT
8.4.2 COMPANY SHARE ANALYSIS
8.4.3 PRODUCT PORTFOLIO
8.4.4 RECENT DEVELOPMENT
8.5 VALAGRO S.P.A.
8.5.1 COMPANY SNAPSHOT
8.5.2 COMPANY SHARE ANALYSIS
8.5.3 PRODUCT PORTFOLIO
8.5.4 RECENT DEVELOPMENTS
8.6 ADAMA (2022)
8.6.1 COMPANY SNAPSHOT
8.6.2 REVENUE ANALYSIS
8.6.3 PRODUCT PORTFOLIO
8.6.4 RECENT DEVELOPMENTS
8.7 ASL
8.7.1 COMPANY SNAPSHOT
8.7.2 PRODUCT PORTFOLIO
8.7.3 RECENT DEVELOPMENT
8.8 AGRINOS
8.8.1 COMPANY SNAPSHOT
8.8.2 PRODUCT PORTFOLIO
8.8.3 RECENT DEVELOPMENT
8.9 ATLÁNTICA AGRICOLA
8.9.1 COMPANY SNAPSHOT
8.9.2 PRODUCT PORTFOLIO
8.9.3 RECENT DEVELOPMENT
8.1 BAYER AG
8.10.1 COMPANY SNAPSHOT
8.10.2 REVENUE ANALYSIS
8.10.3 PRODUCT PORTFOLIO
8.10.4 RECENT DEVELOPMENT
8.11 BIOLCHIM SPA
8.11.1 COMPANY SNAPSHOT
8.11.2 PRODUCT PORTFOLIO
8.11.3 RECENT DEVELOPMENT
8.12 BIOSTADT INDIA LIMITED.
8.12.1 COMPANY SNAPSHOT
8.12.2 PRODUCT PORTFOLIO
8.12.3 RECENT DEVELOPMENT
8.13 BRANDT, INC.
8.13.1 COMPANY SNAPSHOT
8.13.2 PRODUCT PORTFOLIO
8.13.3 RECENT DEVELOPMENT
8.14 KOPPERT
8.14.1 COMPANY SNAPSHOT
8.14.2 PRODUCT PORTFOLIO
8.14.3 RECENT DEVELOPMENT
8.15 MPH
8.15.1 COMPANY SNAPSHOT
8.15.2 PRODUCT PORTFOLIO
8.15.3 RECENT DEVELOPMENT
8.16 NOVOZYMES (2022)
8.16.1 COMPANY SNAPSHOT
8.16.2 REVENUE ANALYSIS
8.16.3 PRODUCT PORTFOLIO
8.16.4 RECENT DEVELOPMENT
8.17 OMEX
8.17.1 COMPANY SNAPSHOT
8.17.2 PRODUCT PORTFOLIO
8.17.3 RECENT DEVELOPMENTS
8.18 TRADE CORPORATION INTERNATIONAL
8.18.1 COMPANY SNAPSHOT
8.18.2 PRODUCT PORTFOLIO
8.18.3 RECENT DEVELOPMENT
9 QUESTIONNAIRE
10 RELATED REPORTS
List of Figure
FIGURE 1 NORTH AMERICA BIOSTIMULANTS MARKET: SEGMENTATION
FIGURE 2 NORTH AMERICA BIOSTIMULANTS MARKET: DATA TRIANGULATION
FIGURE 3 NORTH AMERICA BIOSTIMULANTS MARKET: DROC ANALYSIS
FIGURE 4 NORTH AMERICA BIOSTIMULANTS MARKET: NORTH AMERICA VS REGIONAL MARKET ANALYSIS
FIGURE 5 NORTH AMERICA BIOSTIMULANTS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 NORTH AMERICA BIOSTIMULANTS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 NORTH AMERICA BIOSTIMULANTS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 NORTH AMERICA BIOSTIMULANTS MARKET: MARKET APPLICATION COVERAGE GRID
FIGURE 9 NORTH AMERICA BIOSTIMULANTS MARKET VENDOR SHARE ANALYSIS
FIGURE 10 NORTH AMERICA BIOSTIMULANTS MARKET: SEGMENTATION
FIGURE 11 THE INCREASING NEED FOR SUSTAINABLE AGRICULTURE IS DRIVING THE GROWTH OF THE NORTH AMERICA BIOSTIMULANTS MARKET IN THE FORECAST PERIOD OF 2023 TO 2030
FIGURE 12 ACID-BASED SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICA BIOSTIMULANTS MARKET IN 2023 & 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF THE NORTH AMERICA BIOSTIMULANTS MARKET
FIGURE 14 NORTH AMERICA BIOSTIMULANTS MARKET: SNAPSHOT (2022)
FIGURE 15 NORTH AMERICA BIOSTIMULANTS MARKET: BY COUNTRY (2022)
FIGURE 16 NORTH AMERICA BIOSTIMULANTS MARKET: BY COUNTRY (2023 & 2030)
FIGURE 17 NORTH AMERICA BIOSTIMULANTS MARKET: BY COUNTRY (2022 & 2030)
FIGURE 18 NORTH AMERICA BIOSTIMULANTS MARKET: BY ACITVE INGREDIENTS TYPE (2023-2030)
FIGURE 19 NORTH AMERICA BIOSTIMULANTS MARKET: COMPANY SHARE 2022 (%)
